BioTrack Capital
Overview
BioTrack Capital is a venture capital firm established in 2017 that focuses on investing in and incubating outstanding early-stage biotech, medtech as well as healthcare cross disciplinary sectors (AI and digital healthcare, consumer healthcare etc) . The firm manages four funds and has total assets under management over USD1Bn . Since its inception, BioTrack distinguishes itself as the entrepreneur founded VC with extensive industry ecosystem . Its ecosystem consists of leading global biopahrma, medtech companies and other multinational healthcare conglomerates, which not only provide deep industry insights and value-add service but also empower its portfolio companies in going overseas and global expansion .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Abogen Biosciences | Aug 2021 | Series C | Co-investor |
| MediTrust Health | Mar 2021 | Series B | Co-investor |
| Edge Medical Robotics | Jan 2021 | Series B | Co-investor |
| Valgen Medtech Co., Ltd. | Apr 2019 | Series A | Co-investor |
| Intellective Biologics (Suzhou) Co., Ltd. | Sep 2021 | Series B Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioTrack Capital based?
BioTrack Capital is headquartered in Shanghai, Shanghai, China.
When was BioTrack Capital founded?
BioTrack Capital was founded in 2017.
How many portfolio companies does BioTrack Capital have?
BioTrack Capital has 53 portfolio companies in Caplight's dataset.
What are some companies in BioTrack Capital's portfolio?
Portfolio companies visible on Caplight include Abogen Biosciences, MediTrust Health, Edge Medical Robotics, Valgen Medtech Co., Ltd., Intellective Biologics (Suzhou) Co., Ltd..
What was BioTrack Capital's most recent investment shown here?
BioTrack Capital's most recent investment in this portfolio sample was in Intellective Biologics (Suzhou) Co., Ltd. in 2021.
What sectors does BioTrack Capital focus on?
BioTrack Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Frontier & Industrial Tech, Mobility, Transportation & Logistics, FinTech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does BioTrack Capital focus on?
BioTrack Capital typically invests at the Early stage.
What is BioTrack Capital's AUM?
BioTrack Capital's assets under management are estimated between $500.0M and $1.0B.